『Disrupting Japan』のカバーアート

Disrupting Japan

Disrupting Japan

著者: Tim Romero
無料で聴く

プレミアムプランが3か月 月額99円

登録で500円分のAmazonギフトカードプレゼント。12月23日まで。※適用条件あり
概要
Disrupting Japan gives you candid, in-depth insights from the startup founders, VCs, and leaders who are reshaping Japan.Tim Romero マネジメント・リーダーシップ リーダーシップ 政治・政府 旅行記・解説 社会科学 経済学
エピソード
  • What happens to Japanese anime in the age of AI?
    2026/11/09
    Can we have AI without the AI slop? Theoretically, I suppose we can, but the more pressing question is will we? Today we talk with Takuya Goto, founder of AssetHub, and discuss how AI is now being used by major Japanese animation and game studios. Takuya makes the case that AI slop is just a transitional phase that the industry is already moving beyond. He also has some very direct advice for Japanese founders thinking about doing business overseas. It's a great conversation, and I think you'll enjoy it. Show Notes They key to maintaining quality with AI cost reductions Exporting Japanese animation culture Why Japanese enterprises are the easiest clients for startups to work with Why a Japanese startup targeting Japanese customers should set up in San Francisco The core difference between animation professionals and hobbyists The real cause of the backlash against AI in animation and gaming How to open new global markets in Japanese IP licensing Japan's labor mobility problem (and a few possible solutions) Links from the Founder Everything you ever wanted to know about AssetHub Connect with Takuya on LinkedIn Leave a comment Transcript Welcome to Disrupting Japan, Straight talk from Japan's most innovative founders and VCs. I'm Tim Romero, and thanks for joining me. Over the past few months, there has been an increasing backlash against the use of generative AI in music, in art, and in video games. Well, today's guest is here to explain that while he understands that backlash, the trend itself is inevitable. But not in a bad way. Today we sit down with Takuya Goto, the founder of AssetHub, who explains how AI not only can remove much of the drudgery from video game and animation creation and provide the human artists with a greater artistic control, but how generative AI actually is being used that way today. At major animation studios and AAA game companies. Now, I've got to say, Takuya has a very interesting plan for startup growth. He moved to San Francisco to start his startup there, but from the very beginning, his customer base was always in Japan. Traditionally, this is not something you ever want to do, but Takuya explains why it's not just a good idea today, but why it might become standard practice for Japanese startups in the future. Takuya and I talk about where the global gaming and animation industries are heading, the challenges of maintaining quality in a world increasingly infested with AI slop, and the unique global value held by Japanese game and animation studios. But, you know, Takuya tells that story much better than I can. So, let's get right to the interview. Interview Tim: So, we're sitting here with Takuya Goto, the founder and CEO of AssetHub, which is a generative AI-powered 3D modeling for game asset creation. So, thanks for sitting down with us. Takuya: Ah, yeah. So thanks for inviting me. Tim: Oh, it's absolutely my pleasure. So, as I understand it, the simplest use of AssetHub, a customer can upload just a simple image, and AssetHub will break this into discrete parts and create 3D meshes of each part, and then lets the user edit each part individually. Is that pretty accurate? Takuya: Yes, yeah, it's right. So, we're basically given the AI network for 3D production, especially for making the high-grade contents. So, AI agents to handle the AI native production workflow. Tim: So, can you walk me through a typical use case? How does an average user use your system? Takuya: The general clients are game developers or animation. Actually, the 3D asset is the most expensive part of the production. So, in gaming, around 50% of the whole budget is spent on 3D, like character, environment, or something. And then getting positive is also quite expensive. At least it requires 10 million dollars, so it's 50 million, 100 million, or something, right? So, it's getting higher and higher. This is the biggest bottleneck of creating content. So, we support them to efficiently create a 3D asset. Tim: So, is a customer uploading existing models? Are they uploading just 2D images and sketches? You know, where are they when they start? Takuya: We are giving two services. The one is a self-serve style product. And then another service is FDE. I mean, so we generate 3D model for clients. So, we are working as an AI-based BPO in this case, and they customize the agent for them. First, let me explain the more typical tool usage. At first, users need to give some image to our agents. Sometimes this is a concept art. Giving those images to our agents, and then our agents analyze, okay, this is a human character with anime style. Then this pre-process is required, and they automatically apply those techniques. Separate a single character image into parts, but it requires several efforts. So, we automate that part with agents. So, give image, agent analyze and think about what is the best way to reproduce 3D model, and then just apply those techniques, and then general 3D model. So, user experience ...
    続きを読む 一部表示
    1分未満
  • What Japan’s CVCs can teach the rest of us
    2026/10/12
    The future of Japanese industry depends on startups. At some point in the early 2000s the seemingly unstoppable engine of Japanese corporate innovation mysteriously began to spin down. Product quality was still high, of course, but corporate R&D seemed increasingly unable to launch anything truly innovative. Today we sit down with Nicolas Sauvage, President of TDK Ventures, who explains how Japanese enterprise is increasingly looking to startups to fill that gap. And it's working. We talk about what makes for successful enterprise-startup collaboration, how startup innovations are being adopted within enterprises, and exactly who CVC units really need to answer to. It's a great conversation, and I think you'll enjoy it. Show Notes How the parent's history and DNA effects CVC TDK Venture's four-year innovation horizon A strategy for finding and investing in innovative startups How to convince an enterprise to start a CVC unit The false dichotomy between financial and strategic concerns How CVCs can reliably drive innovation back to their parent Exploration vs exploitation CVC strategies The importance of (and difficulty in) investor transparency and accountability Tracking TDK Ventures' anti-portfolio What will drive Japanese innovation over the next decade Why the parent is not the CVC unit's customer Links from the Founder Everything you ever wanted to know about TDK Ventures TDK Ventures intro deck TDK United Reports TDK Ventures Deep Explorations Nicolas' Podcast: Corporate Venturing Insider [youtube.com] Nicolas' SubStack: From Frontier to Iconic [nicolassauvage.substack.com] Articles Nicolas & I discussed How VCs Can Create a Winning Investment Thesis [hbr.org] The Cold Email VCs Want [medium.com] Entrepreneurs Deserve a Better No [medium.com] Our Customer Is The Entrepreneur [usv.com] AM Batteries–ATL collaboration announcement [businesswire.com] Further Reading on building and running a CVC What Successful Corporate Venture Capital Funds Do Differently [hbr.org] The Opinionated CVC: A perspective on strategy, process and people Open-Source TDK Mothership Startup Engagements Tracker Open-source TDK Ventures Investment Scorecard What You Need to Unlearn to Succeed in Venture Capital Why VCs Should Use Net Promoter Scores with Founders [hbr.org] Is Corporate Venture Capital Right for Your Startup? [hbr.org] Starting a Corporate VC: An Olympic Approach [medium.com] Corporate Venturing: The Infinite Relay Race [medium.com] Leave a comment Transcript Welcome to Disrupting Japan, Straight talk from Japan's most innovative founders and VCs. I'm Tim Romero, and thanks for joining me. Venture capital is an industry that is defined by trends. Not only the technology trends that dominate the headlines, but by quieter, equally powerful trends that are going on behind the scenes. Over the last decade, Japanese enterprises have become increasingly active startup investors. They do this by making LP investments in other VC funds, having business units make startup investments directly. And increasingly, by setting up corporate venture capital teams to focus full-time on startup investing and collaboration. Results so far have been, shall we say, mixed. While a handful of Japanese CVCs have delivered tremendous strategic and financial value to their parent companies, others have spent a lot of money with very little to show for it. Well, today we're going to sit down and talk with someone who is doing things right, Nicolas Sauvage, the president of TDK Ventures. I helped set up both TEPCO and JERA's CVC units, and I've always been impressed with the way TDK Ventures runs things, so it's great to have Nicolas on the show. We dive into what corporate sponsors should actually expect from their CVC units, how TDK selects startups and makes investment decisions, and some of the most important reasons to be optimistic about the future of corporate venture capital in Japan. But you know, Nicolas tells that story much better than I can. So, let's get right to the interview. Interview Tim: So, we're sitting here with Nicolas Sauvage, the president of TDK Ventures. So, thanks for sitting down with me. Nicolas: No, it's great to be with you, Tim. Tim: To get started, TDK makes all kinds of things, but I think most consumers still associate them with magnetic tape. So, before we get into TDK Ventures, what is TDK? What do you guys do? Nicolas: Well, let's start with the history of TDK, maybe, because that, I think, is part of the charm, as you say. So, it started in 1935, 91 years ago, as a venture company. And it was a spin-off of a university. Saito-san, the founder, had failed 98 startups before. It was his attempt number 99. Tim: TDK started as a university startup spin-out. Nicolas: In a way, it leveraged on licensed technology coming from a university. It was around ferrite materials, which at the time was a frontier material. They started plowing and commercializing these ferrite materials for different use ...
    続きを読む 一部表示
    51 分
  • The Japanese startup killing the nasal swab
    2026/09/14
    Sometimes it seems like Japan just can't figure out medtech startups. In theory, Japan should be one of the most active startup markets for medical technology. In practice, however, there are relatively few success cases. Today we are going to meet one of those success cases and talk with Sho Okiyama, MD and founder of Aillis, who has developed a minimally invasive flu and covid test that is already in widespread use in Japan. Hopefully, no one will ever need to stick another swab up your nose. We also talk about Sho's time as a rural doctor, what's straining Japan's healthcare system, and how to fix it before it breaks. It's a great conversation, and I think you'll enjoy it. Show Notes Why influenza diagnosis has been so resistant to AI You’ll never get another swab stuck up your nose What practicing as a rural doctor taught Sho about Japan's healthcare system Some Japanese still turn to Shamanism for medical advice Starting an AI startup without a technical founder Building a medical training dataset from scratch The challenge Anthropic and OpenAI face in medical tech Aillis's plans for global expansion Why there are so few medtech startup in Japan and how to fix that How to drive meaningful change in Japanese society Links from the Founder Everything you ever wanted to know about Aillis Learn more about Evidence Finder Connect with Sho on LinkedIn Friend him on Facebook Follow him on Twitter @ShoOkiyama Watch Sho's TEDx talk on AI development in modern medicine Leave a comment Transcript Welcome to Disrupting Japan, Straight talk from Japan's most innovative founders and VCs. I'm Tim Romero, and thanks for joining me. Japan has a real problem with life science startups. I mean, there's no shortage of brilliant ideas and patents. There's no shortage of support programs and investors looking to invest in Japanese medtech and biotech startups. Everyone in Japan wants this to happen. Everyone knows this is about to happen. And yet, everyone is also a bit frustrated at just how slow this is happening. But of course, it is happening. So, today we sit down with Sho Okiyama, medical doctor and founder of Aillis, who has developed an AI-powered throat camera that can actually diagnose both influenza and COVID. It's the first device of its kind ever approved as a diagnostic medical device, and it is already in widespread use in clinics and hospitals in every prefecture in Japan. It's really an amazing success story that is just getting started. Sho and I talk about what it really takes to bring a new medical device to market in Japan, what it's like to be the only doctor on a string of remote Japanese islands, and how we're going to get more Japanese doctors to start startups. But you know, Sho tells that story much better than I can. So, let's get right to the interview. Interview Tim: So, we're sitting here with Sho Okiyama, the founder and CEO of Aillis, who is using AI to make medical diagnosis faster and more accurate. So, thanks for sitting down with me. Sho: Thank you for having me, Tim. Tim: I'm really looking forward to this, because I think there's so much innovation going on in biotech and medicine in Japan right now, and what you guys are doing is really interesting. So, you've got two products, and I'd like to kind of cover them briefly. First, you have the Nodoka diagnostic camera. Sho: We produce Nodoka, which is a medical device. This is a pharyngoscope. In other words, it's a throat camera. So, whenever you go to the doctor, the doctor would take a look at your throat, right? You know, find out whether it's reddish, swelling, or something like that. But all those inspections were based on knowledge inside the doctor's brain. So, what we developed was the database of the pharyngeal photo. Tim: So, when a doctor is looking at someone's throat, they're looking for all kinds of different things. But Nodoka, as I understand it, is looking for two very specific things, right? It's able to diagnose influenza and recently COVID as well, right? Sho: Yes. We used to diagnose influenza and COVID using PCR or similar methods. Tim: How accurate is it compared to the PCR test? Because I would be very, very happy if I never have to get another swab up my nose for testing these things. Sho: Yeah. Nodoka has gone through a clinical trial and has proven that it has approximately equivalent accuracy compared to the antigen testing. Tim: That's fantastic. And it's in widespread use already, right? Sho: Yes. It has been introduced to more than 2,000 hospitals or clinics in Japan. Tim: And is the driving factor just patient comfort? Nobody likes getting the swab up the nose? Or is it more accurate? Is it faster? Sho: Yeah, it's faster. And of course, it's less invasive, right? And what's more, Nodoka only has indications for two different diseases as of now, but it has the potential to have more indications, like cancers such as tongue cancer or pharyngeal cancer. And we also wrote a paper that the AI is able to...
    続きを読む 一部表示
    1分未満
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません